Clinical Trials Update: Jan. 17, 2007
Rheumatoid Arthritis Alzheimer's Disease Healthy Patient Studies
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
If you taking methotrexate for rheumatoid arthritis and your symptoms still bother you, you may be eligible for this study. Volunteers at least 18 who have active rheumatoid arthritis, are taking 10 mg. to 25 mg. of methotrexate per week, and have at least six tender joints and at least six swollen joints may qualify. The study medication will be taken daily for 12 weeks.
The research site is in Vero Beach, Fla.
This study will evaluate whether the investigational drug is a safe and effective treatment for people with mild-to-moderate Alzheimer's disease. Candidates 50-90 may be included who have a standardized MMSE score of 10 to 24 points and a diagnosis of probable AD using established criteria.
The research sites are located across the United States.
Healthy Patient Studies
Healthy volunteers are needed for a research study of risk factors for cardiovascular disease. Volunteers must be ages 18 to 40, healthy, and must not use tobacco. Qualified participants will be paid $1,100 for completing the study and receive free study related examinations.
The research site is in Philadelphia, Penn.
Copyright 2007 Thomson CenterWatch. All rights reserved.